Project Grant S10OD034422

Award Date 6/15/24
Completion Date 6/14/25
Dollars Obligated $1
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $738,090 to the University of California, Irvine (UCI) to purchase a refurbished Orbitrap Eclipse Tribrid mass spectrometer. The new instrument will enable a major user group at UCI to conduct enhanced quantitative protein-based mass spectrometry experiments in support of multiple NIH-funded research programs. Key applications include...
This $1,574,994 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a high-resolution tandem mass spectrometer to support large molecule structural characterization research at the University of California, Los Angeles (UCLA). The state-of-the-art mass spectrometer, equipped with electrospray ionization and various activation/dissociation methods, will enable advanced analysis of a broad range of...
This National Science Foundation (NSF) Integrative Activities (CFDA 47.083) Project Grant award of $401,144 to the University of the Pacific (Stockton, CA) will fund the acquisition of a Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometer (MALDI-TOF-MS). This high-resolution mass spectrometry instrument will support collaborative research and educational programs across multiple departments at the university. The grant will enable advanced structural analyses of...
The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $750,000 Project Grant (CFDA 93.351) to The Ohio State University to permanently acquire a Bruker timsTOF Flex MALDI-2 quadrupole time-of-flight mass spectrometer. This advanced imaging mass spectrometer will empower NIH-funded investigators at Ohio State and Case Western Reserve University in their tissue imaging studies, providing three critical new capabilities: MALDI-2 post-ionization,...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $750,000 to Stanford University to acquire a Bruker timsTOF Flex MALDI-2 mass spectrometer. The instrument will be used to support spatial single-cell omics research at Stanford's Center for Genomics and Personalized Medicine. This state-of-the-art mass spectrometer will enable researchers to study the spatial distribution of small molecules, such as...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1 to the University of Illinois Chicago (UIC), a federally designated minority-serving institution, to acquire a dual-source ion mobility mass spectrometry system. The new state-of-the-art instrumentation will enable advanced proteomic, lipidomic, and metabolomic measurements to support diverse biomedical research projects...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,089,778 to The Regents of the University of Colorado (CU-Boulder) to purchase a high-resolution liquid chromatography-mass spectrometry system. The new instrument, consisting of a Waters Select Series Cyclic IMS QTOF mass spectrometer, ACQUITY PREMIER UPLC, and ACQUITY HDX Manager UPLC, will support small molecule, biomolecule, and post-translational...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), awarded a $1,469,739 Project Grant to the Research Foundation of the City University of New York (RFCUNY) to purchase a TIMSTOF-FLEX MALDI-2 high-resolution mass spectrometer. This advanced instrumentation will support biomedical research projects across 12 laboratories from CUNY and nearby institutions, focusing on areas such as conformational dynamics of...
This $250,000 Project Grant award, provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351), will enable Montana State University Billings (MSUB) to acquire an Agilent 1290 Infinity Series II Ultra-High-Performance Liquid Chromatography (UHPLC) system integrated with an Agilent 6530 Quadrupole Time-of-Flight (QTOF) mass spectrometer. This cutting-edge analytical instrumentation will support advanced biomedical research and education at MSUB,...
This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...

A MALDI-QTOF FOR BIOMOLECULAR SPATIAL PHENOTYPING - PROJECT ABSTRACT FUNDING IS REQUESTED TO ACQUIRE A STATE-OF-THE-ART MASS SPECTROMETER FOR MALDI IMAGING MASS SPECTROMETRY (MALDI IMS) IN SUPPORT OF MULTIPLE NIH-FUNDED PROGRAMS AT UC IRVINE. THE INSTRUMENT IS BASED ON A AP-MALDI-QTOF DESIGN OPTIMIZED FOR IMAGING BY HIGH-SPEED, HIGH RESOLUTION ACQUISITION OF MASS SPECTRA FROM RASTER LASER SCANNING OF MATRIX-COATED 2D SPECIMENS. MALDI IMS PROVIDES A PROVEN TECHNIQUE CAPABILITY OF RETAINING SPATIAL INFORMATION ALONGSIDE HIGH DIMENSIONAL ION MASS DETECTION. SUPPORTED PROJECTS ORIGINATE FROM RESEARCHERS IN THE SCHOOLS OF PHYSICAL SCIENCES, BIOLOGICAL SCIENCES, ENGINEERING, MEDICINE AND PHARMACY & PHARMACEUTICAL SCIENCES. THE INSTRUMENT WILL, THEREFORE, BE TRULY A SHARED INTER-DISCIPLINARY RESOURCE. PROJECTS OF THE MAJOR USERS INCLUDE, 1) NEUROPATHOLOGICAL PROTEINS AND LIPID PHENOTYPING IN ALZHEIMER'S DISEASE MODELS, 2) INVESTIGATING METABOLIC HETEROGENEITY IN TUMORS, 3) EVALAUTING ECM COMPOSITION OF ENGINEERED CARTILAGE, 4) DEFINING AGE/ENVIRONMENTAL CHANGES OF LENS CYRSTALLINS, 5) SPATIAL PLANT METABOLOMICS AND 5) ASSESSING LIPID/PROTEIN DISTRIBUTIONS IN DRY EYE SYNDROME. ALL THE PROJECTS ARE PURSUANT OF HIGHLY DEFINED GOALS WHERE THE SPATIAL ORGANIZATION OF BIOMOLECULES (METABOLITES, LIPIDS, PEPTIDES/PROTEINS) IS A CRITICAL COMPONENT FOR UNDERSTANDING THE MOLECULAR ORGANIZATION AND FUNCTION OR DYSFUNCTION OF TISSUES. FOR OPTIMAL ACCESS, MAINTENANCE AND EXPERT OPERATIONAL SUPPORT, THE INSTRUMENT WILL BE PLACED IN UCI'S MASS SPECTROMETRY CORE FACILITY. UCI HAS LONG SUPPORTED THE MSF WITH PERMANENT FUNDING FOR FULL-TIME FACILITY STAFF MEMBERS: A PHD-LEVEL DIRECTOR WITH >30 YEARS EXPERIENCE AS A MULTIDISCIPLINARY RESEARCH SCIENTIST, COMPLEMENTED BY A PROTEOMICS SPECIALIST WITH EXPERTISE IN MALDI AND LC-MS TECHNIQUES, AND AN INSTRUMENT OPERATOR. NORMAL FACILITY OPERATIONAL FUNDS ARE OBTAINED THOUGH A WELL ESTABLISHED STABLE RECHARGE SYSTEM. ADDITIONAL EXTENDED SERVICE SUPPORT IS PROVIDED THROUGH PLEDGED INSTITUTIONAL FUNDS. ALL 20 INSTRUMENTS IN THE FACILITY ARE INTENSIVELY USED, PARTICULARLY FOR SMALL MOLECULE ANALYSIS, TOP DOWN PROTEOMICS AND METABOLOMICS WITH MOST AVAILABLE 24/7 AS WALK-UP OPEN ACCESS INSTRUMENTS. IN FISCAL YEAR 2021-2022 THE FACILITY ANALYZED >35K SAMPLES BY 300 USERS, WITH MANY USERS RECEIVING ADVANCED INSTRUMENT TRAINING. THE MALDI-IMS INSTRUMENT WILL BE RUN AS A STAFF-OPERATED SERVICE BUT ALSO MADE ACCESSIBLE TO QUALIFIED TRAINED USERS TO MAINTAIN A HIGH SAMPLE THROUGHPUT AND MAXIMUM USE. THE RESEARCH OUTLINED IN THE PROPOSAL HIGHLIGHTS AN URGENT NEED FOR AN ADVANCED BUT USER-FRIENDLY INSTRUMENT THAT IS NOT CURRENTLY AVAILABLE AT UCI; A FAST MALDI-QTOF IMS SYSTEM FOR HIGH QUALITY BIOMOLECULAR SPATIAL PHENOTYPING.

Posted 6/10/24